(PharmaNewsWire.Com, March 16, 2017 ) According to the report “Asia-Pacific Nuclear Medicines radiopharmaceuticals Market” published by Market Data Forecast, the Asia-Pacific market was worth $855 million in 2015 and is projected to reach $1670 million with CAGR of 14.3% by 2020.
Nuclear medicine falls under the field of molecular imaging, which requires minute amount of radioactive material in order to treat or diagnose diseases. The market of radiopharmaceuticals is overshadowed by Diagnostic radioisotopes and Therapeutic radioisotopes. The inclination of radiopharmaceuticals in cancer medications has increased as research institutes have developed methods for employing radioisotopes to impede the maturation of malignant tumors, cells, and tissues.
Based on market share estimation, radiopharmaceuticals market is dominated by diagnostic radioisotopes and covers 90% of the shares in the market, while therapeutic radioisotopes contribute ten percent of the market. The F-18 market is mostly contributed by F-18 FDG tracers, although this market will be in abundance with future tracers such as F-18 Florbetapir and F-18 Choline.
Rising demand in PET and SPECT imaging application increases the growth of this market. Also increase in number of people getting diagnosed with cancer and heart diseases, recent technological advancement and increasing awareness among the masses regarding these technologies has been major drivers for the growth in nuclear radiopharmaceuticals market. Integration of X- ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market.
Some of the key players influencing the North America nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.
The Asia-Pacific Nuclear Medicines radiopharmaceuticals Market study offers following deliverables: • Global Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped. • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics. • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis. • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development. • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment. • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies. • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions. • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout other related studies in the Pharmaceuticals Segment:
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
